Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

"Saviour siblings".

M Spriggs1, J Savulescu

  • 1Ethics Unit, Murdoch Childrens Research Institute, Royal Childrens Hospital, Flemington Road, Parkville, Victoria, 3052, Australia. spriggsm@murdoch.rch.unimelb.edu.au

Journal of Medical Ethics
|October 3, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Human brain changes after first psilocybin use.

Nature communications·2026
Same author

Commercial Impacts on Assisted Reproductive Technology: A Scoping Review.

Journal of bioethical inquiry·2025
Same author

Ethical and practical questions in satisfying the human right to unconsciousness at the end of life: a reply.

Anaesthesia·2021
Same author

General anaesthesia does not inevitably result in apnoea or require ventilatory support.

Anaesthesia·2021
Same author

General anaesthesia in end-of-life care: extending the indications for anaesthesia beyond surgery.

Anaesthesia·2021
Same author

A right to be unconscious.

Anaesthesia·2019
Same journal

Suicide is not a public health issue and perhaps very few things should be.

Journal of medical ethics·2026
Same journal

Normalising transparency: an argument for requiring generative AI use declarations in all manuscripts-with a call for commentaries.

Journal of medical ethics·2026
Same journal

Not all personal utilities are equal: a two-tier normative framework for genomic health technology assessment.

Journal of medical ethics·2026
Same journal

Correction: Harms of the current global anti-FGM campaign.

Journal of medical ethics·2026
Same journal

Emergent ethics of xenotransplantation: findings from a survey on public attitudes toward animal to human organ transplantation in the UK.

Journal of medical ethics·2026
Same journal

Is sport in the 'public interest'? Towards a legal and ethical framework for justifying sport-related harm.

Journal of medical ethics·2026
See all related articles

Victorian authorities permit tissue typing with preimplantation genetic diagnosis for in vitro fertilization (IVF). This allows selecting embryos free of genetic disease and matching for stem cell donation to treat a sick sibling.

Area of Science:

  • Reproductive medicine
  • Genetics
  • Stem cell therapy

Background:

  • Preimplantation genetic diagnosis (PGD) is used to screen embryos for genetic disorders.
  • Tissue typing is a method to match donor and recipient tissues.
  • In vitro fertilization (IVF) enables fertilization outside the body.

Purpose of the Study:

  • To report the approval of combining tissue typing with PGD in Victoria.
  • To highlight a novel application of IVF for dual embryo selection.
  • To enable selection of embryos free from genetic disease and suitable for stem cell donation.

Main Methods:

  • Utilizing in vitro fertilization (IVF) techniques.
  • Implementing preimplantation genetic diagnosis (PGD) for genetic screening.
Keywords:
Genetics and ReproductionHuman Fertilisation and Embryology AuthorityProfessional Patient Relationship

Related Experiment Videos

  • Performing tissue typing to assess HLA compatibility.

    • Main Results:

    • Permission granted for combined tissue typing and PGD in Victoria.
    • Potential for selecting embryos free of genetic disorders.
    • Capability to select embryos for HLA matching for sibling stem cell transplantation.

    Conclusions:

    • This combined approach represents a significant advancement in assisted reproductive technologies.
    • It offers a dual benefit of preventing genetic diseases and facilitating life-saving stem cell therapies.
    • The approval paves the way for new therapeutic possibilities in genetic and hematologic disorders.